Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma has changed the face of prenatal screening and diagnosis. The technique has moved to become a high-efficiency screening test for Down Syndrome’s and is finding an ever-increasing number of applications. This presentation brings you up to date with the subject.